We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
AUM
$183M
AUM Growth
-$20.1M
Cap. Flow
-$21.5M
Cap. Flow %
-11.72%
Top 10 Hldgs %
66.27%
Holding
72
New
7
Increased
15
Reduced
40
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 55.8%
2 Healthcare 32.81%
3 Industrials 1.95%
4 Financials 1.85%
5 Consumer Discretionary 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCLR
1
DELISTED
Oclaro Inc.
OCLR
$57.4M 31.31%
10,630,367
-54,322
-0.5% -$229K
FNSR
2
DELISTED
Finisar Corp
FNSR
$11M 6.03%
605,571
-56,358
-9% -$811K
NEO icon
3
NeoGenomics
NEO
$2.39B
$9.63M 5.25%
1,428,548
-138,978
-9% -$915K
XENT
4
DELISTED
Intersect ENT, Inc
XENT
$9.28M 5.06%
488,643
-69,696
-12% -$1.26M
TLGT
5
DELISTED
Teligent, Inc
TLGT
$8.73M 4.76%
178,197
-13,158
-7% -$820K
GIMO
6
DELISTED
Gigamon Inc.
GIMO
$8.25M 4.5%
265,930
-18,765
-7% -$490K
SRGA
7
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$5.5M 3%
45,824
-2,955
-6% -$310K
IL
8
DELISTED
IntraLinks Holdings Inc.
IL
$4.47M 2.44%
567,940
-84,195
-13% -$661K
EMKR
9
DELISTED
Emcore Corp
EMKR
$3.74M 2.04%
74,797
-287,745
-79% -$15.6M
OMCL icon
10
Omnicell
OMCL
$1.52B
$3.44M 1.87%
123,247
-2,170
-2% -$59.6K
LGND icon
11
Ligand Pharmaceuticals
LGND
$5.67B
$3.33M 1.82%
49,908
+1,033
+2% +$62.8K
ATRC icon
12
AtriCure
ATRC
$2.51B
$3.24M 1.77%
192,446
-5,439
-3% -$95.7K
NXTM
13
DELISTED
NxStage Medical Inc.
NXTM
$2.5M 1.36%
166,932
-2,680
-2% -$44.9K
SWKS icon
14
Skyworks Solutions
SWKS
$10.1B
$2.46M 1.34%
31,623
-96
-0.3% -$6.51K
IDTI
15
DELISTED
Integrated Device Technology I
IDTI
$2.43M 1.33%
119,070
-31,630
-21% -$665K
ENZ
16
DELISTED
Enzo Biochem, Inc.
ENZ
$2.22M 1.21%
487,724
-103,150
-17% -$459K
RKUS
17
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$2.16M 1.18%
220,640
-33,095
-13% -$306K
AKRX
18
DELISTED
Akorn Inc
AKRX
$2.13M 1.16%
90,585
-2,695
-3% -$70.9K
CALD
19
DELISTED
Callidus Software, Inc.
CALD
$2.08M 1.14%
+124,871
New +$1.85M
PODD icon
20
Insulet
PODD
$9.95B
$1.91M 1.04%
57,547
-14,064
-20% -$442K
KTWO
21
DELISTED
K2M Group Holdings, Inc
KTWO
$1.9M 1.04%
127,998
+26,118
+26% +$359K
QRVO icon
22
Qorvo
QRVO
$8.49B
$1.89M 1.03%
37,449
+53
+0.1% +$2.31K
CEMP
23
DELISTED
Cempra, Inc.
CEMP
$1.79M 0.98%
102,411
+13,755
+16% +$249K
CVLT icon
24
Commault Systems
CVLT
$5.82B
$1.75M 0.96%
40,557
+841
+2% +$31.1K
VG
25
DELISTED
Vonage Holdings Corporation
VG
$1.56M 0.85%
340,425
-1,170
-0.3% -$5.78K

Similar funds

Kopp Investment Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Kopp Investment Advisors held 72 positions worth $183M, down 9.9% from $203M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Kopp Investment Advisors withdrew a net $21.5M in Q1 2016, closing 6 positions and reducing 40 holdings. Its most notable exit was Pernix Therapeutics Holdings, Inc., an estimated $931K position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 49% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Kopp Investment Advisors opened a new position in Callidus Software, Inc. worth $2.08M.

  • Kopp Investment Advisors's largest Q1 2016 buy was Callidus Software, Inc.: 124,871 shares worth $2.08M.
  • Kopp Investment Advisors added most to SPS Commerce in Q1 2016, an estimated $452K increase.
  • Kopp Investment Advisors's biggest Q1 2016 reduction was Emcore Corp, cutting an estimated $15.6M.
  • Kopp Investment Advisors fully exited Pernix Therapeutics Holdings, Inc. in Q1 2016, selling an estimated $931K.
  • Kopp Investment Advisors's ten largest holdings make up 66% of its $183M portfolio in Q1 2016.
  • Kopp Investment Advisors opened 7 new positions and closed 6 in Q1 2016.
  • Kopp Investment Advisors's portfolio value fell 9.9% quarter-over-quarter to $183M.

Based on Kopp Investment Advisors's 13F filing for Q1 2016, filed 16 May 2016.